Advertisement

Advertisement

DMAC Stock Latest News

DiaMedica Therapeutics reports Q1 EPS (19c), consensus (19c)

The FlyDiaMedica Therapeutics reports Q1 EPS (19c), consensus (19c)

DiaMedica sees cash, equivalents funding operations through 2027

PremiumThe Fly

DiaMedica sees cash, equivalents funding operations through 2027

3h ago

DiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks

PremiumCompany Announcements

DiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks

1M ago

DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update

PremiumCompany Announcements

DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update

1M ago

DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)

PremiumThe Fly

DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)

1M ago

DMAC Upcoming Earnings Report: What to Expect?

PremiumPre-EarningsDMAC Upcoming Earnings Report: What to Expect?

1M ago

DiaMedica Therapeutics receives Health Canada clearance to initiate DM199 study

The Fly

DiaMedica Therapeutics receives Health Canada clearance to initiate DM199 study

2M ago

Omega takes new stake in Rocket Companies, exits ArriVent Biopharma

The Fly

Omega takes new stake in Rocket Companies, exits ArriVent Biopharma

3M ago

DiaMedica Therapeutics Raises Capital via Share Offering

PremiumCompany Announcements

DiaMedica Therapeutics Raises Capital via Share Offering

4M ago

DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street

PremiumThe Fly

DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street

4M ago

DiaMedica Therapeutics provides DM199 update following FDA meeting

PremiumThe Fly

DiaMedica Therapeutics provides DM199 update following FDA meeting

5M ago

DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting

PremiumCompany Announcements

DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting

5M ago

Buy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress

PremiumRatingsBuy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress

6M ago

Microsoft initiated, Home Depot downgraded: Wall Street’s top analyst calls

The Fly

Microsoft initiated, Home Depot downgraded: Wall Street’s top analyst calls

6M ago

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

The Fly

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

6M ago

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

PremiumThe Fly

DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald

6M ago

DiaMedica Therapeutics Reports Q3 2025 Financial Results

PremiumCompany Announcements

DiaMedica Therapeutics Reports Q3 2025 Financial Results

6M ago

DiaMedica Therapeutics’ Earnings Call: Mixed Outlook

PremiumCompany Announcements

DiaMedica Therapeutics’ Earnings Call: Mixed Outlook

6M ago

DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress

PremiumCompany Announcements

DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress

6M ago

DiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)

PremiumThe FlyDiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)

6M ago

DMAC Earnings this Week: How Will it Perform?

Pre-Earnings

DMAC Earnings this Week: How Will it Perform?

6M ago

DiaMedica Therapeutics initiated with a Buy at TD Cowen

The Fly

DiaMedica Therapeutics initiated with a Buy at TD Cowen

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >